[1]
|
徐建国. 成人术后疼痛治疗进展[J]. 临床麻醉学杂志, 2011, 27(3): 299-301.
|
[2]
|
Barletta, J.F. (2012) Clinical and Economic Burden of Opioid Use for Postsurgical Pain: Focus on Ventilatory Impairment and Ileus. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 32, 12S-18S. https://doi.org/10.1002/j.1875-9114.2012.01178.x
|
[3]
|
张杰, 刘永飞, 曹建泽, 等. 多模式镇痛在全膝关节置换术中应用的研究进展[J]. 骨科, 2024, 15(6): 568-572.
|
[4]
|
张黄丽, 殷昌生, 贾晓姝, 等. 布比卡因脂质体术后镇痛应用进展[J]. 武警医学, 2023, 34(6): 530-534.
|
[5]
|
Cheung, B.M., Ng, P.Y., Liu, Y., Zhou, M., Yu, V., Yang, J., et al. (2021) Pharmacokinetics and Safety of Liposomal Bupivacaine after Local Infiltration in Healthy Chinese Adults: A Phase 1 Study. BMC Anesthesiology, 21, Article No. 197. https://doi.org/10.1186/s12871-021-01407-5
|
[6]
|
Alfirevic, A., Almonacid-Cardenas, F., Yalcin, E.K., Shah, K., Kelava, M., Sessler, D.I., et al. (2024) Blood Bupivacaine Concentrations after Pecto-Serratus and Serratus Anterior Plane Injections of Plain and Liposomal Bupivacaine in Robotically-Assisted Mitral Valve Surgery: Sub-Study of a Randomized Trial. Journal of Clinical Anesthesia, 95, Article ID: 111470. https://doi.org/10.1016/j.jclinane.2024.111470
|
[7]
|
Gorfine, S.R., Onel, E., Patou, G. and Krivokapic, Z.V. (2011) Bupivacaine Extended-Release Liposome Injection for Prolonged Postsurgical Analgesia in Patients Undergoing Hemorrhoidectomy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Diseases of the Colon & Rectum, 54, 1552-1559. https://doi.org/10.1097/dcr.0b013e318232d4c1
|
[8]
|
Habib, A.S., Nedeljkovic, S.S., Horn, J., Smiley, R.M., Kett, A.G., Vallejo, M.C., et al. (2021) Randomized Trial of Transversus Abdominis Plane Block with Liposomal Bupivacaine after Cesarean Delivery with or without Intrathecal Morphine. Journal of Clinical Anesthesia, 75, Article ID: 110527. https://doi.org/10.1016/j.jclinane.2021.110527
|
[9]
|
Paul, J.E., Arya, A., Hurlburt, L., Cheng, J., Thabane, L., Tidy, A., et al. (2010) Femoral Nerve Block Improves Analgesia Outcomes after Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials. Anesthesiology, 113, 1144-1162. https://doi.org/10.1097/aln.0b013e3181f4b18
|
[10]
|
Kim, M.K., Ko, S.H., Hwang, Y.J., Kwon, D.G., Jeon, Y.S. and Ryu, D.J. (2022) Effectiveness of Continuous Femoral Nerve Block for Pain Relief after Total Knee Arthroplasty: Comparison with Epidural Patient-Controlled Analgesia and Periarticular Injection. Journal of International Medical Research, 50, 1-12. https://doi.org/10.1177/03000605221085062
|
[11]
|
Hadzic, A., Minkowitz, H.S., Melson, T.I., Berkowitz, R., Uskova, A., Ringold, F., et al. (2016) Liposome Bupivacaine Femoral Nerve Block for Postsurgical Analgesia after Total Knee Arthroplasty. Anesthesiology, 124, 1372-1383. https://doi.org/10.1097/aln.0000000000001117
|
[12]
|
Dobson, S.W., Stouffer, N.D., Weller, R.S., Shields, J.S., Edwards, C.J. and Henshaw, D.S. (2023) Comparison of Femoral Nerve Catheter, Adductor Canal Catheter, and Periarticular Liposomal Bupivacaine Infiltration for Postoperative Analgesia after Primary Total Knee Arthroplasty. The Journal of Arthroplasty, 38, 824-830. https://doi.org/10.1016/j.arth.2022.11.015
|
[13]
|
Fu, H., Wang, J., Zhang, W., Cheng, T. and Zhang, X. (2015) Potential Superiority of Periarticular Injection in Analgesic Effect and Early Mobilization Ability over Femoral Nerve Block Following Total Knee Arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy, 25, 291-298. https://doi.org/10.1007/s00167-015-3519-6
|
[14]
|
Al-Saati, M.F., Alaqaili, S.I., Alshammari, F.A., ElRaei, M.A.N., Albaiz, A.A., Tushinski, D., et al. (2023) The Efficacy and Safety of Subcutaneous Continuous Local Infiltration Analgesia with Ropivacaine in Patients Undergoing Total Knee Arthroplasty: A Comparative Study. BMC Musculoskeletal Disorders, 24, Article No. 214. https://doi.org/10.1186/s12891-023-06263-7
|
[15]
|
Ukai, T., Kosuke, H., Ebihara, G. and Watanabe, M. (2020) Comparison of Periarticular Multidrug Infiltration and Epidural Catheter Use in Total Knee Arthroplasty: A Prospective Randomized Controlled Study. Journal of Orthopaedic Surgery, 28, 1-6. https://doi.org/10.1177/2309499020910663
|
[16]
|
Kuang, M., Du, Y., Ma, J., He, W., Fu, L. and Ma, X. (2017) The Efficacy of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. The Journal of Arthroplasty, 32, 1395-1402. https://doi.org/10.1016/j.arth.2016.12.025
|
[17]
|
Hamilton, T.W., Knight, R., Stokes, J.R., Rombach, I., Cooper, C., Davies, L., et al. (2022) Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee Replacement: A Randomized Clinical Trial. JAMA Surgery, 157, 481-489. https://doi.org/10.1001/jamasurg.2022.0713
|
[18]
|
Feng, J.E., Ikwuazom, C.P., Mahure, S.A., Waren, D.P., Slover, J.D., Schwarzkopf, R.S., et al. (2021) Discontinuation of the Liposomal Delivery of Bupivacaine Has No Effect on Pain Management after Primary Total Knee Arthroplasty: No Effect on Pain Scores, Opioid Consumption, or Functional Status. The Bone & Joint Journal, 103, 102-107. https://doi.org/10.1302/0301-620x.103b6.bjj-2020-2033.r1
|
[19]
|
Hussain, N., Brull, R., Sheehy, B.T., Kushelev, M., Essandoh, M.K. and Abdallah, F.W. (2020) The Mornings After—Periarticular Liposomal Bupivacaine Infiltration Does Not Improve Analgesic Outcomes beyond 24 Hours Following Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. Regional Anesthesia & Pain Medicine, 46, 61-72. https://doi.org/10.1136/rapm-2020-101995
|
[20]
|
Kuang, M., Ma, J., Fu, L., He, W., Zhao, J. and Ma, X. (2017) Is Adductor Canal Block Better than Femoral Nerve Block in Primary Total Knee Arthroplasty? A GRADE Analysis of the Evidence through a Systematic Review and Meta-analysis. The Journal of Arthroplasty, 32, 3238-3248.e3. https://doi.org/10.1016/j.arth.2017.05.015
|
[21]
|
Li, D. and Ma, G. (2015) Analgesic Efficacy and Quadriceps Strength of Adductor Canal Block versus Femoral Nerve Block Following Total Knee Arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy, 24, 2614-2619. https://doi.org/10.1007/s00167-015-3874-3
|
[22]
|
Li, D., Yang, Z., Xie, X., Zhao, J. and Kang, P. (2015) Adductor Canal Block Provides Better Performance after Total Knee Arthroplasty Compared with Femoral Nerve Block: A Systematic Review and Meta-Analysis. International Orthopaedics, 40, 925-933. https://doi.org/10.1007/s00264-015-2998-x
|
[23]
|
Hubler, C.P., Bevil, K.M., Greiner, J.J., Hetzel, S.J., Borden, S.B. and Cios, H.A. (2021) Liposomal Bupivacaine versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: A Randomized, Controlled Trial. Orthopedics, 44, 249-255. https://doi.org/10.3928/01477447-20210621-01
|
[24]
|
Quaye, A., McAllister, B., Garcia, J.R., Nohr, O., Laduzenski, S.J., Mack, L., et al. (2024) A Prospective, Randomized Trial of Liposomal Bupivacaine Compared to Conventional Bupivacaine on Pain Control and Postoperative Opioid Use in Adults Receiving Adductor Canal Blocks for Total Knee Arthroplasty. Arthroplasty, 6, Article No. 6. https://doi.org/10.1186/s42836-023-00226-y
|
[25]
|
Malige, A., Pellegrino, A.N., Kunkle, K., Konopitski, A.K., Brogle, P.J. and Nwachuku, C.O. (2022) Liposomal Bupivacaine in Adductor Canal Blocks before Total Knee Arthroplasty Leads to Improved Postoperative Outcomes: A Randomized Controlled Trial. The Journal of Arthroplasty, 37, 1549-1556. https://doi.org/10.1016/j.arth.2022.03.073
|
[26]
|
Rice, D., Heil, J.W. and Biernat, L. (2017) Pharmacokinetic Profile and Tolerability of Liposomal Bupivacaine Following a Repeated Dose via Local Subcutaneous Infiltration in Healthy Volunteers. Clinical Drug Investigation, 37, 249-257. https://doi.org/10.1007/s40261-017-0495-2
|
[27]
|
Springer, B.D., Mason, J.B. and Odum, S.M. (2018) Systemic Safety of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty. The Journal of Arthroplasty, 33, 97-101. https://doi.org/10.1016/j.arth.2017.07.038
|
[28]
|
Sessler, D.I., Bao, X., Leiman, D., Song, J., Chittenden, J., Voelkner, A., et al. (2024) A Phase I Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Liposomal Bupivacaine for Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy. The Journal of Clinical Pharmacology, 65, 441-451. https://doi.org/10.1002/jcph.6159
|
[29]
|
Cohen, B., Glosser, L., Saab, R., Walters, M., Salih, A., Zafeer‐Khan, M., et al. (2018) Incidence of Adverse Events Attributable to Bupivacaine Liposome Injectable Suspension or Plain Bupivacaine for Postoperative Pain in Pediatric Surgical Patients: A Retrospective Matched Cohort Analysis. Pediatric Anesthesia, 29, 169-174. https://doi.org/10.1111/pan.13561
|
[30]
|
Tirotta, C.F., de Armendi, A.J., Horn, N.D., Hammer, G.B., Szczodry, M., Matuszczak, M., et al. (2021) A Multicenter Study to Evaluate the Pharmacokinetics and Safety of Liposomal Bupivacaine for Postsurgical Analgesia in Pediatric Patients Aged 6 to Less than 17 Years (Play). Journal of Clinical Anesthesia, 75, Article ID: 110503. https://doi.org/10.1016/j.jclinane.2021.110503
|
[31]
|
(2018) EXPAREL [Package Insert]. Pacira Pharmaceuticals Inc.
|
[32]
|
European Medicines Agency (2021) EMEA/H/C/004586/2021-Exparel Liposomal: EPAR-Product Information 2020. https://www.ema.europa.eu/en/documents/product-information/exparel-liposomal-epar-product-information_en.pdf
|